Overview

Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas

Status:
Terminated
Trial end date:
2004-05-11
Target enrollment:
Participant gender:
Summary
The goal is to assess survival and patterns of failure in patients treated with Gemzar-based chemoradiation and TNP-470 for locally advanced adenocarcinoma of the pancreas.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Gemcitabine
O-(Chloroacetylcarbamoyl)fumagillol
Pancreatin
Pancrelipase